VivoSeq
Nephrology

Renal Blood Flow

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Renal Blood Flow is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Unknown status3 · 75%
Completed1 · 25%

Clinical Trials

Trial Activity

Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Completed·—·Phase 2·NCT00714142·30 enrolled
Study of Renal Blood Flow During Human Endotoxemia
Unknown status·—·N/A·NCT00413465·32 enrolled
Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram
Unknown status·UUniversity of Virginia·N/A·NCT01544036·150 enrolled
Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound
Unknown status·UUniversity of Virginia·Phase 1/2·NCT02672722·19 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)